Back
Amylyx Pharmaceuticals Stock Price Chart
Sell
24
AMLX
Amylyx Pharmaceuticals
Last Price:
1.84
Seasonality Move:
87.32%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing slight selling pressure.
Amylyx Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Sell |
| 20-day SMA: | 1.89 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 13.39 | Sell |
| 8-day EMA: | 1.85 | Sell |
| 20-day EMA: | 2.04 | Sell |
| 50-day EMA: | 4.09 | Sell |
| 200-day EMA: | 12.39 | Sell |
Amylyx Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 29.71 | Sell |
| Chaikin Money Flow: | -407380 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2) | Sell |
| Bollinger Bands (100): | (2.29 - 16.29) | Sell |
Amylyx Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amylyx Pharmaceuticals Stock
Is Amylyx Pharmaceuticals Stock a Buy?
- Amylyx Pharmaceuticals share price is 1.83 while AMLX 8-day simple moving average is 1.84, which is a Sell signal.
- The stock price of AMLX is 1.83 while Amylyx Pharmaceuticals 20-day SMA is 1.89, which makes it a Sell.
- Amylyx Pharmaceuticals 50-day simple moving average is 2.38 while AMLX share price is 1.83, making it a Sell technically.
- AMLX stock price is 1.83 and Amylyx Pharmaceuticals 200-day simple moving average is 13.39, creating a Sell signal.
AMLX Technical Analysis vs Fundamental Analysis
Sell
24
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy or a Sell?
-
Amylyx Pharmaceuticals stock is rated a Sell
The current Amylyx Pharmaceuticals [AMLX] share price is $1.83. The Score for AMLX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Amylyx Pharmaceuticals Stock Info
Market Cap:
124.45M
Price in USD:
1.83
Share Volume:
1.22M
Amylyx Pharmaceuticals 52-Week Range
52-Week High:
27.98
52-Week Low:
1.70
Sell
24
Amylyx Pharmaceuticals (AMLX)
is a Sell
Amylyx Pharmaceuticals Share Price Forecast
-
What is the Amylyx Pharmaceuticals stock price today?
The Amylyx Pharmaceuticals stock price is 1.83 USD today. -
Will AMLX stock go up or go down?
Amylyx Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Amylyx Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amylyx Pharmaceuticals is overvalued.
Is Amylyx Pharmaceuticals Stock a Buy?
- Amylyx Pharmaceuticals share price is 1.83 while AMLX 8-day exponential moving average is 1.85, which is a Sell signal.
- The stock price of AMLX is 1.83 while Amylyx Pharmaceuticals 20-day EMA is 2.04, which makes it a Sell.
- Amylyx Pharmaceuticals 50-day exponential moving average is 4.09 while AMLX share price is 1.83, making it a Sell technically.
- AMLX stock price is 1.83 and Amylyx Pharmaceuticals 200-day simple moving average is 12.39, creating a Sell signal.
Fundamental Analysis of Amylyx Pharmaceuticals
Is Amylyx Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.19 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Amylyx Pharmaceuticals
Should I short Amylyx Pharmaceuticals stock?
- AMLX Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Amylyx Pharmaceuticals is a Sell
- Amylyx Pharmaceuticals Relative Strength Index (RSI) is 29.71, which suggest Amylyx Pharmaceuticals is oversold
- The Bollinger Bands (25) for Amylyx Pharmaceuticals is (1.82 - 2), which suggest Amylyx Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Amylyx Pharmaceuticals is (2.29 - 16.29), which suggest Amylyx Pharmaceuticals is a Sell
* Amylyx Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.